Viome PRO published a report titled Beyond the Scope: The Non-Invasive Revolution Reshaping Colorectal Cancer Screening by Scope Forward.
Public source
Publisher name
Public post
The next breakthrough in colorectal cancer screening may not be another biomarker. It may be something far less glamorous: Making sure every positive non-invasive test l…
Company
Viome PRO
Imagine a world where illness is optional.
- Industry
- Wellness and Fitness Services
- Location
- Bellevue, US
- Company size
- 11–50 employees
About Viome PRO
Viome Life Sciences was founded in 2016 with a mission to make illness optional by predicting and preventing chronic diseases, cancers, and aging through a deeper understanding of an individual's biology at a molecular level. The Viome Pro division leverages proprietary RNA sequencing technology, exclusively licensed from Los Alamos National Laboratory, and AI to develop non-invasive early detection tests for high-mortality cancers and chronic diseases.
See moreLatest activity
Latest activity from Viome PRO
3 signals
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
Omni-Biotic (AllergoSan USA)
Omni-Biotic (AllergoSan USA) published a new paper investigating whether baseline gut microbiome and metabolomic profiles could predict response to a one-year structured weight-loss intervention in 50 adults with obesity.
Research & Knowledge
SMART STRAINS
SMART STRAINS published an article reviewing Registered Dietitian Nichola Ludlam-Raine BSc (hons), PG Dip, MSc, detailing 7 simple steps to support children's health during back-to-school season.
Research & Knowledge
Previvor Edge
Previvor Edge has improved colorectal cancer detection through a blood test, noting that polyps are often missed before they become cancer.
Research & Knowledge
Ancient Nutrition
Ancient Nutrition published a webinar discussing how to rebuild butyrate production and why cell membrane decisions affect nutrition.
Research & Knowledge
Noom